NCT02398292View on ClinicalTrials.gov

A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
SchizophreniaPsychotic Disorders
Interventions
OTHER

M3 Program

Participants and their study partners will learn about food, movement, and mindfulness through hands-on curriculum.

OTHER

Control

Participants will not participate in M3 program but will have same outcomes measured at same time points (baseline, 6 weeks, 12 weeks).

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT02398292 - A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis | Biotech Hunter | Biotech Hunter